Healthcare Professional Substance Abuse Statistics 2026: Physician and Nurse Numbers, New England Data, and a Medical Director's Read on What They Mean

Healthcare professionals spend their careers treating other people's illnesses, and a meaningful number quietly carry one of their own. It is also one of the worst-sourced topics in addiction: the same numbers circulate from page to page, usually uncited, often decades old, sometimes traceable to a study of a few dozen people.

This page rebuilds the statistics from primary sources only: federal survey data, peer-reviewed cohort studies, CDC surveillance, and the state programs that actually monitor clinicians in New Hampshire and Massachusetts. Every figure carries its source and its year.

Key numbers at a glance

Each figure below links to its primary source, with the year the data were collected or published noted inline.

• 5.7 percent of full-time health care and social assistance workers had a past-year substance use disorder, versus 9.5 percent across all industries; heavy alcohol use (4.4 percent) and illicit drug use (5.5 percent) also ran below the all-industry averages of 8.7 and 8.6 percent (SAMHSA, combined 2008-2012 NSDUH data, published 2015).
• For national context, 48.4 million Americans aged 12 or older (16.8 percent) had a past-year substance use disorder in 2024 (SAMHSA, 2024 NSDUH, published 2025).
• 12.9 percent of male physicians and 21.4 percent of female physicians met diagnostic criteria for alcohol abuse or dependence in a survey of 7,288 doctors (Oreskovich et al., The American Journal on Addictions, 2015).
• 0.86 percent of anesthesiology residents developed a substance use disorder during training between 1975 and 2009, with the highest incidence occurring after 2003 (Warner et al., JAMA, 2013).
• Among registered nurses, 37.8 percent reported past-year substance use (including alcohol), 11.4 percent screened positive for a substance use problem, and 6.6 percent for a potential substance use disorder (Trinkoff et al., Journal of Nursing Regulation, 2022; data collected 2020-2021).
• The claim that "69 percent of physicians have misused prescription drugs" comes from a focus-group study of 55 physicians already in monitoring for substance-related impairment (Merlo et al., Journal of Addiction Medicine, 2013).
• 78.7 percent of physicians treated through state physician health programs were licensed and working five years later, based on 904 physicians admitted 1995-2001 (McLellan et al., BMJ, 2008).
• Health workers' mean days of poor mental health rose from 3.3 to 4.5 per month between 2018 and 2022, and the share reporting burnout "very often" rose from 11.6 to 19.0 percent (CDC Vital Signs, MMWR, 2023).
• Female physicians die by suicide at 1.46 times the rate of women in the general population; male physicians at 0.67 times the rate of men overall, with both ratios falling since 1980 (Duarte et al., JAMA Psychiatry, 2020).
• Published investigations identified six drug-diversion-linked bacterial outbreaks affecting 80 patients between 1991 and 2019, with 93 percent of patients presenting with bloodstream infections (Open Forum Infectious Diseases, 2025).

How common is substance use disorder among healthcare professionals?

The only occupation-level federal estimate comes from SAMHSA's report on substance use by industry, built on combined 2008-2012 National Survey on Drug Use and Health data for full-time workers aged 18 to 64 and published in 2015. It found that health care and social assistance workers reported past-month heavy alcohol use of 4.4 percent, past-month illicit drug use of 5.5 percent, and a past-year substance use disorder rate of 5.7 percent. All three figures sit well below the all-industry averages of 8.7, 8.6, and 9.5 percent.

Two honest caveats belong next to those numbers. No comparably detailed federal occupational table has replaced them, so any page presenting them as current is misdating its evidence. And industry averages hide the concentrations that make this topic matter: alcohol among physicians, prescription-type misuse among nurses, intravenous opioids in anesthesia.

For context, the 2024 NSDUH, published in July 2025, found that 48.4 million Americans aged 12 or older, 16.8 percent, met criteria for a past-year substance use disorder. Survey methodology changed in 2021, so the modern national rate cannot be compared directly against the 2008-2012 occupational figures.

One more pattern worth naming: clinicians are often the textbook case of high-functioning professionals with addiction. Training rewards stamina and self-reliance, performance stays intact long after use becomes disordered, and colleagues are slow to suspect someone competent.

Physician substance abuse statistics

What the prevalence research actually shows

The largest modern prevalence study is Oreskovich and colleagues' 2015 survey in The American Journal on Addictions, which invited 27,276 U.S. physicians and analyzed 7,288 responses. It found that 12.9 percent of male physicians and 21.4 percent of female physicians met diagnostic criteria for alcohol abuse or dependence. Misuse of prescription drugs and use of illicit drugs were rare in this sample. Alcohol, not narcotics, is the dominant substance problem in medicine, and it clustered with burnout, depression, suicidal ideation, and recent medical errors.

Anesthesiology: the real specialty-risk numbers

Anesthesiology's occupational risk is real, but the folklore version ("40 percent use IV drugs") is not. The definitive study is Warner and colleagues' 2013 JAMA cohort of all 44,612 physicians who began U.S. anesthesiology residency between 1975 and 2009. Over 177,848 resident-years, 384 residents (0.86 percent) developed a substance use disorder during training, most commonly involving intravenous opioids, with incidence highest from 2003 onward. The outcomes were sobering: 28 of the 384 (7.3 percent) died during training, all deaths related to the disorder, and an estimated 43 percent of survivors relapsed at least once within 30 years.

Where the "69 percent of physicians" myth comes from

One statistic dominates search results: "69 percent of physicians have misused prescription drugs." Its actual source is a 2013 study by Merlo and colleagues in the Journal of Addiction Medicine, which ran guided focus groups with exactly 55 physicians, 94.5 percent of them male, every one already being monitored by a state physician health program because of substance-related impairment. Within that already-impaired group, 69.1 percent reported a history of misusing prescription drugs, most often to self-treat pain, emotional distress, or stress.

The figure describes physicians already diagnosed with substance dependence, not physicians in general, and versions of it now circulate re-attributed to surveys that do not exist. When you see it, check the citation trail; it ends at those 55 doctors.

Nurse substance abuse statistics: the honest numbers

The "1 in 5 nurses" figure has no source

"10 to 15 percent of nurses" and "1 in 5 nurses" appear on nursing career sites, continuing-education modules, and treatment-industry pages, and never with a primary citation. A rigorous, recent alternative exists, and it deserves to replace the trope.

What the 2022 Nurse Worklife and Wellness Study found

The Nurse Worklife and Wellness Study (Trinkoff et al., Journal of Nursing Regulation, 2022) surveyed a stratified random sample of licensed registered nurses in nine states from November 2020 to March 2021, analyzing 1,170 usable responses. Its findings, presented to the National Council of State Boards of Nursing in 2024:

Source: Trinkoff et al., Journal of Nursing Regulation, 2022.

The definitional ladder explains why the folklore range never dies: quote the broad past-year-use figure and nurses look alarming; quote the screening-based disorder figure and they look comparable to other American adults. The study team put the nurses' 6.6 percent potential-disorder rate beside a 7.4 percent general-population rate (SAMHSA's 2020 survey). What is distinctive about nurses is the pattern, not the volume: prescription-type misuse, at 9.9 percent, exceeded general-population norms and tracked with workplace exposure: availability, frequent administration, and weaker handling controls.

Pharmacists, dentists, and EMS professionals

Almost every page stops at doctors and nurses; the evidence for other clinicians is thinner and older, which is itself worth stating plainly.

Pharmacists. The key study remains Kenna and Wood's 2004 survey of dentists, nurses, pharmacists, and physicians in a northeastern state (2002 data, 68.7 percent response). Past-year drug use was highest among pharmacists at 12.8 percent, and pharmacists reported more lifetime use of minor opiates, anxiolytics, and stimulants, consistent with what they handle daily. Overall dysfunction levels were low across professions.

Dentists. The companion 2005 study in The Journal of the American Dental Association found dentists reported more past-year heavy episodic drinking than physicians, but concluded there was little evidence that dentists face greater overall substance-use risk than the general population.

EMS professionals. Occupation-specific substance use disorder prevalence for EMTs and paramedics has never been well measured, and the round numbers found online for them are unsourced. What is documented is the exposure: SAMHSA's first-responder behavioral health research bulletin (2018) compiles studies showing 69 percent of EMS professionals report never having enough recovery time between traumatic events, and 37 percent of fire and EMS personnel have contemplated suicide, roughly ten times the rate reported by American adults overall. Chronic trauma exposure without recovery time is a well-established driver of substance use.

Why healthcare workers are at risk

Three occupational forces recur across every study of clinician addiction.

Access and diversion opportunity. Clinicians handle controlled substances as routine work. The anesthesiology data above show what proximity does: the specialty's signature risk is intravenous opioids, the drugs its practitioners draw up daily. In the nurse data, workplace exposure, including perceived availability and administration frequency, predicted prescription-type misuse (Trinkoff et al., 2022).

Shift work, fatigue, and pain. The 2022 nurse study team linked higher prescription-type misuse to greater job demands and adverse work schedules, the long shifts and irregular hours that define bedside care. Physical strain adds a second pathway: injuries and chronic pain put clinicians in contact with the same medications they administer, and self-treatment is culturally normalized in medicine. In the Merlo focus groups (2013), managing physical pain was the first reason monitored physicians gave for prescription misuse.

Burnout and moral injury. The current, sourced backdrop is the CDC's 2023 Vital Signs report on health-worker mental health, which compared 2018 and 2022 survey waves. Health workers' mean days of poor mental health in the past month rose from 3.3 to 4.5, the share reporting burnout "very often" rose from 11.6 to 19.0 percent, reported workplace harassment more than doubled from 6.4 to 13.4 percent, and 45.6 percent reported burnout often or very often in 2022. Health workers were also more likely than other workers to report negative changes in their working conditions across those years. Untreated distress of this kind is the soil in which substance problems grow.

"The clinicians I treat rarely started the way people imagine. It is almost never recreational at first. It is a back injury, an unraveling marriage, a night-shift stretch that never ends, plus a locked cabinet they can open. The culture teaches us to treat ourselves and to never be the patient, and that instinct fails clinicians faster than it fails anyone else, because the substances are within reach and the self-monitoring is already compromised."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Drug diversion statistics: what post-2021 reporting actually shows

For years, articles about diversion leaned on a single vendor-published industry digest whose last full reporting year was 2020. Citing it in 2026 means citing pre-pandemic data from a vendor marketing report, not from surveillance. Here is what actually exists now.

There is no current national count of diversion incidents. No federal agency publishes an annual tally of drug diversion by healthcare personnel, and honest pages say so. What has been published since 2021 is narrower and better sourced: a 2023 narrative review in the Canadian Journal of Anesthesia cataloguing prevention strategies in perioperative settings, and a 2025 framework study in Research in Social and Administrative Pharmacy that identified 20 categories of system vulnerability across five themes, from verification gaps in wastage processes to the limits of electronic systems at flagging discrepancies, that make hospital diversion possible.

The patient-safety stakes are documented. The CDC maintains a clinician brief on drug diversion because tampering with injectable opioids transmits infections. A 2025 analysis in Open Forum Infectious Diseases of investigations spanning 1990-2023 identified six published diversion-associated bacterial outbreaks between 1991 and 2019, involving 80 patients, 93 percent of whom presented with bloodstream infections; four of the six outbreaks involved tampering with patient-controlled analgesia pumps. These counts capture only investigated, published outbreaks, a floor rather than a ceiling.

Regulators treat diversion as a health issue as well as a crime. The National Council of State Boards of Nursing frames substance use disorder in nursing as a treatable chronic disease and maintains education, guidance, and alternative-to-discipline resources for state boards, on the logic that early referral to treatment protects patients better than punishment-only responses that drive impaired clinicians underground.

Mental health, suicide, and dual diagnosis among clinicians

The physician suicide number most pages quote is not a real count. The claim that "300 to 400 physicians die by suicide every year" circulates widely without a primary source; it is an old extrapolation, not surveillance data. The current best evidence is the 2020 meta-analysis by Duarte and colleagues in JAMA Psychiatry, covering post-1980 cohorts: female physicians die by suicide at 1.46 times the rate of women in the general population (95 percent CI, 1.02-1.91), while male physicians die at 0.67 times the rate of men overall (95 percent CI, 0.55-0.79). Ratios for both sexes have declined significantly since 1980. A newer 2024 BMJ meta-analysis of 39 studies from 20 countries agreed: elevated rates for female physicians (rate ratio 1.76 across all study eras), none overall for male physicians, and effect sizes decreasing over time. The elevated risk among women physicians is real and demands attention; the flat 400-per-year figure deserves retirement.

Distress and substance problems travel together. In the Oreskovich physician survey (2015), alcohol abuse and dependence clustered with burnout, depression, suicidal ideation, lower quality of life, and recent medical errors. This overlap is the clinical reality behind dual diagnosis: treating the substance use while leaving depression, anxiety, or post-traumatic symptoms unaddressed invites relapse, which is why integrated dual diagnosis treatment is standard of care for clinicians as much as for anyone else.

Consequences: licensure, discipline, and patient safety

Statistics about license actions are among the least sourced in this field; percentage claims about how many disciplined clinicians keep or lose their licenses generally trace to nothing. The honest, sourced picture comes from the monitoring literature. In the McLellan five-year cohort (BMJ, 2008), among 904 physicians admitted to 16 state physician health programs between 1995 and 2001, five-year outcomes were: 78.7 percent licensed and working, 10.8 percent with licenses revoked, 3.5 percent retired, 3.7 percent deceased, and 3.2 percent unknown. Even in a structured, supportive monitoring system, roughly one in nine physicians lost their license, and the stakes of untreated progression, for careers and for the patients in these clinicians' care, are exactly why early, voluntary help matters.

The contrast without that structure is documented too. In the matched anesthesiology cohort (Warner et al., Anesthesiology, 2015), residents who developed a substance use disorder had 14.9 times the odds of failing to complete residency, 6.8 times the hazard of adverse medical licensure actions after training, and 7.9 times the risk of death compared with matched controls. These cohort numbers are what the peer-reviewed record actually supports.

For nurses, state boards publish disciplinary actions individually rather than as national SUD-attributable percentages, and NCSBN promotes alternative-to-discipline programs precisely because board discipline that ends a career also ends the board's ability to require treatment and monitoring.

Signs of an impaired colleague and what to do

The workplace signs that nursing regulators and researchers describe are consistent: frequent medication errors, frequent wasting of controlled substances, incomplete documentation, patients reporting inadequate pain relief, volunteering unusually often to administer medications, many absences or long breaks, and changes in reliability or behavior. In the Nurse Worklife and Wellness Study's companion survey data (presented to NCSBN, 2024), fewer than half of nurses, 47.7 percent, felt confident they could identify an impaired colleague by appearance or behavior, yet 93 percent said they would report a suspected case to a supervisor and 82.4 percent said they would try to help the colleague.

Reporting obligations vary by state and profession, but the common structure is the same: concerns go to a supervisor or directly to the state's professional health program, which can trigger a confidential evaluation rather than an automatic disciplinary case. The point of reporting is not punishment; it is interrupting a progression that, in a hospital, carries patient safety on its back.

Physician health programs and monitoring: what the outcome numbers really say

A note on acronyms, because this field has a genuinely confusing collision: in the professional-monitoring literature, "PHP" means physician health program, a state-level monitoring body. In treatment settings, including at Clear Steps Recovery, PHP means partial hospitalization program, a full-day outpatient level of care also called day treatment. This section uses "PHP" only in the monitoring sense.

The outcome study behind nearly every success-rate claim online is McLellan and colleagues' 2008 BMJ cohort: 904 physicians consecutively admitted to 16 state physician health programs from September 1995 to September 2001. The real numbers: 19.3 percent of physicians with known outcomes failed their program, usually early. Of the 647 who completed treatment and returned to supervised practice, 19 percent had alcohol or drug misuse detected by urine testing at some point over five years. At five-year follow-up, 78.7 percent of the full cohort were licensed and working.

Those are excellent outcomes by addiction-treatment standards, far better than the unmonitored norms described in our relapse statistics guide. But when a page reports "71 percent five-year sobriety" or "75 to 90 percent success" as current data, it is quoting this 1995-2001 cohort, published in 2008 and recycled through reviews since, as in a 2016 surgical review reporting "more than 70 percent able to practice at 5 years." The finding held up; the dates belong next to it. It also describes physicians in intensive, sanction-backed monitoring, a structure most of the public never receives.

New Hampshire and Massachusetts: programs, boards, and local context

No national statistics page covers the state layer, yet for a clinician deciding whether to seek help, the state layer is what matters. Here is the New England picture, from the primary sources.

New Hampshire. The New Hampshire Professionals' Health Program (NH PHP) is an independent nonprofit serving licensed health professionals across the state, including physicians, physician assistants, nurses, pharmacists, dentists, chiropractors, mental health practitioners, psychologists, veterinarians, and others. Its peer-assistance services span assessment, treatment referral, and monitoring, for concerns ranging from substance use to burnout, and the program describes itself as free and confidential as required by law or regulation. Working with NH PHP is typically how a New Hampshire clinician gets help while protecting a license rather than risking it.

Massachusetts. Physicians, residents, and medical students have Physician Health Services (PHS), a nonprofit founded by the Massachusetts Medical Society that provides confidential consultation, assessment, referral, monitoring, and support for substance use, mental health, and behavioral concerns. For nurses, the Board of Registration in Nursing has long operated the Substance Addiction Recovery Program (SARP), a non-disciplinary rehabilitation pathway. In December 2024, Massachusetts consolidated monitoring into the Unified Recovery and Monitoring Program (URAMP), created under Chapter 177 of the Acts of 2022: a confidential, voluntary recovery and monitoring program covering licensees of all 22 boards under the Bureau of Health Professions Licensure, for both substance use and mental health concerns. That statutory, confidential front door is barely a year old, and almost no statistics page mentions it.

Why this region concentrates the issue. Greater Boston is one of the densest healthcare employment markets in the country, anchored by its teaching hospitals and systems that also draw clinical staff from southern New Hampshire. A high concentration of clinicians means a high concentration of everything in this article: the exposure, the burnout, and the need for treatment options that respect licensure. Clear Steps Recovery serves this corridor from Londonderry, New Hampshire and Needham, Massachusetts.

The re-baseline table: where the recycled statistics actually come from

This table reconciles the numbers most often published about healthcare professionals against their true origins and the current best data. It exists because no other page in this topic provides it.

"When a clinician sits across from me and quotes one of these statistics about themselves, either as reassurance or as doom, we usually spend part of that first visit unlearning it. The folklore numbers make addiction in medicine look either universal or unbeatable, and both readings keep people from acting. What I want a worried nurse or physician to take from the honest data is simpler: this is common enough that nobody should feel like the only one, and treatable enough that getting evaluated early is the rational move."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

Confidential treatment for licensure-constrained clinicians

The practical question for a healthcare professional is rarely "does treatment exist" but "how do I get treatment without vanishing from my job and triggering the exact scrutiny I fear." Levels of care answer that question differently, and matching the level to the clinical picture is the core decision.

• Standard outpatient care provides weekly or twice-weekly therapy while a clinician keeps working, for early-stage problems or step-down after more intensive treatment.
• Intensive outpatient programs (IOP) provide roughly 9 or more hours of structured group and individual treatment per week, scheduled around work. For licensed professionals whose evaluations support outpatient care, an intensive outpatient program is where treatment and employment coexist.
• Virtual IOP delivers the same structure by secure telehealth, which matters for clinicians in rural New Hampshire, on irregular schedules, or with privacy concerns about a local waiting room; our virtual IOP overview explains how it works.
• Day treatment, also called partial hospitalization (the treatment-setting sense of PHP, distinct from the physician health programs discussed above), provides full clinical days while the person sleeps at home; see day treatment in New Hampshire. It fits clinicians on leave who need more structure than IOP without a residential stay.
• Medication-assisted treatment. For opioid and alcohol use disorders, medication-assisted treatment is evidence-based standard care. Monitoring bodies handle medications case by case rather than by blanket rule, so medication support and professional monitoring are not mutually exclusive. Treatment teams coordinate with monitoring programs on documentation and toxicology so the plan satisfies both.
• Medically supervised withdrawal. When detox is clinically necessary first, Clear Steps Recovery does not provide it on site; the team refers to trusted detox partners and coordinates the transition into outpatient care afterward.

Two design features matter for licensed professionals in any of these settings. First, documentation: monitoring agreements typically require attendance records, progress reports, and toxicology results, and a treatment program experienced with clinicians builds those in rather than treating them as intrusions. Second, return-to-work sequencing: treatment intensity steps down as monitoring steps up, the structure the physician health program outcomes above validate.

"A licensed professional who cannot disappear for ninety days is not out of options; in most cases outpatient structure is the clinically appropriate choice anyway, because they recover while still inside the life they are protecting. What I tell clinicians is that the monitoring program and the treatment program are not opposing forces. When the two coordinate, the monitoring becomes scaffolding, and the data we have on monitored clinicians should make anyone hopeful about what recovery in this profession looks like."

Dr. Richard Marasa, Medical Director, Clear Steps Recovery

The bottom line

Healthcare professionals develop substance use disorders at rates somewhat below the workforce average on the best federal data, concentrated in alcohol for physicians, prescription-type medications for nurses, and intravenous opioids in anesthesia. The most quoted statistics in this field are either unsourced or describe small, already-impaired samples; the honest numbers are less sensational and more hopeful, because monitored clinicians show some of the strongest long-term recovery outcomes ever published. In New Hampshire and Massachusetts, confidential professional health programs mean a clinician who reaches out early can protect both their license and their life. In a crisis, call or text 988.

Methodology and sourcing notes

Every statistic on this page comes from a primary source: federal agencies (SAMHSA, CDC), peer-reviewed journals (BMJ, JAMA, JAMA Psychiatry, the Journal of Nursing Regulation, and others), or the official state and professional bodies that run clinician monitoring programs. No figure was taken from treatment-industry blogs or aggregator sites. Each number is labeled with the year its data were collected or published, including the widely recycled figures this page corrects, whose origins are documented in the re-baseline table; occupational federal data date to 2008-2012 and are identified as such, with the 2024 National Survey on Drug Use and Health (published July 2025) supplying national context. Every citation URL was verified live before publication; two Massachusetts state pages (URAMP and SARP) block automated access and were confirmed through the live public search index and program documentation. This page was medically reviewed by Dr. Richard Marasa, and the draft pull quotes attributed to him are pending his final approval. Last reviewed July 3, 2026.